vs
CHAIN BRIDGE BANCORP INC（CBNA）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
ROCKWELL MEDICAL, INC.的季度营收约是CHAIN BRIDGE BANCORP INC的1.2倍（$18.3M vs $14.7M），CHAIN BRIDGE BANCORP INC净利率更高（36.4% vs -3.0%，领先39.4%），CHAIN BRIDGE BANCORP INC自由现金流更多（$11.5M vs $2.2M）
该公司原为公开上市的多元化银行控股集团，总部位于芝加哥近郊，由杰拉尔德·菲茨杰拉德创立，菲茨杰拉德家族持有其多数股权。1994年，该公司被蒙特利尔银行合并收购，蒙特利尔银行旗下美国子公司哈里斯银行集团通过此次合并，扩大了哈里斯银行在芝加哥地区的业务布局，这笔全股票交易估值约2.46亿美元。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
CBNA vs RMTI — 直观对比
营收规模更大
RMTI
是对方的1.2倍
$14.7M
净利率更高
CBNA
高出39.4%
-3.0%
自由现金流更多
CBNA
多$9.3M
$2.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $18.3M |
| 净利润 | $5.3M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | 45.6% | -2.2% |
| 净利率 | 36.4% | -3.0% |
| 营收同比 | — | -25.6% |
| 净利润同比 | — | 26.7% |
| 每股收益（稀释后） | $0.81 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBNARMTI
| Q4 25 | $14.7M | $18.3M | ||
| Q3 25 | $13.1M | $15.9M | ||
| Q2 25 | $12.6M | $16.1M | ||
| Q1 25 | $14.5M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | $16.7M | $28.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $22.7M |
净利润CBNARMTI
| Q4 25 | $5.3M | $-554.0K | ||
| Q3 25 | $4.7M | $-1.8M | ||
| Q2 25 | $4.6M | $-1.5M | ||
| Q1 25 | $5.6M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $7.5M | $1.7M | ||
| Q2 24 | — | $343.0K | ||
| Q1 24 | — | $-1.7M |
毛利率CBNARMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率CBNARMTI
| Q4 25 | 45.6% | -2.2% | ||
| Q3 25 | 44.9% | -9.9% | ||
| Q2 25 | 45.8% | -8.4% | ||
| Q1 25 | 48.4% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | 56.3% | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -5.8% |
净利率CBNARMTI
| Q4 25 | 36.4% | -3.0% | ||
| Q3 25 | 35.8% | -11.0% | ||
| Q2 25 | 36.3% | -9.3% | ||
| Q1 25 | 38.6% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 44.8% | 5.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -7.6% |
每股收益（稀释后）CBNARMTI
| Q4 25 | $0.81 | $-0.01 | ||
| Q3 25 | $0.72 | $-0.05 | ||
| Q2 25 | $0.70 | $-0.05 | ||
| Q1 25 | $0.85 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $1.64 | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $586.6M | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $169.2M | $37.0M |
| 总资产 | $1.8B | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBNARMTI
| Q4 25 | $586.6M | $10.7M | ||
| Q3 25 | $395.7M | $13.6M | ||
| Q2 25 | $377.3M | $12.5M | ||
| Q1 25 | $629.2M | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | $639.8M | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
股东权益CBNARMTI
| Q4 25 | $169.2M | $37.0M | ||
| Q3 25 | $163.1M | $37.0M | ||
| Q2 25 | $156.9M | $30.4M | ||
| Q1 25 | $151.5M | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $104.8M | $29.1M | ||
| Q2 24 | — | $23.5M | ||
| Q1 24 | — | $20.6M |
总资产CBNARMTI
| Q4 25 | $1.8B | $57.1M | ||
| Q3 25 | $1.5B | $57.5M | ||
| Q2 25 | $1.4B | $52.6M | ||
| Q1 25 | $1.7B | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | $1.6B | $57.1M | ||
| Q2 24 | — | $53.0M | ||
| Q1 24 | — | $50.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $11.5M | $2.2M |
| 自由现金流率自由现金流/营收 | 78.1% | 12.0% |
| 资本支出强度资本支出/营收 | 28.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.92× | — |
| 过去12个月自由现金流最近4个季度 | $17.9M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流CBNARMTI
| Q4 25 | $15.6M | $2.3M | ||
| Q3 25 | $2.8M | $-1.3M | ||
| Q2 25 | $3.4M | $1.8M | ||
| Q1 25 | $3.1M | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-2.4M |
自由现金流CBNARMTI
| Q4 25 | $11.5M | $2.2M | ||
| Q3 25 | $2.5M | $-1.5M | ||
| Q2 25 | $2.5M | $1.7M | ||
| Q1 25 | $1.4M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
自由现金流率CBNARMTI
| Q4 25 | 78.1% | 12.0% | ||
| Q3 25 | 18.7% | -9.6% | ||
| Q2 25 | 20.0% | 10.5% | ||
| Q1 25 | 9.8% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
资本支出强度CBNARMTI
| Q4 25 | 28.0% | 0.5% | ||
| Q3 25 | 2.5% | 1.4% | ||
| Q2 25 | 6.5% | 1.0% | ||
| Q1 25 | 11.6% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
现金转化率CBNARMTI
| Q4 25 | 2.92× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBNA
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
